David G. Miller, MD
Director, Center for Merkel Cell Carcinoma, Massachusetts General Hospital / Massachusetts General Brigham Cancer Institute
The goal of this activity is for learners to be better able to identify patients with basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (CSCC) who would not be ideal candidates for surgery-only management and would be appropriate to receive treatment with chemo- and immunotherapy approaches.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
Pricing
100% of listed courses are free
300 of a sample of 300 are free · 1,253 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
Director, Center for Merkel Cell Carcinoma, Massachusetts General Hospital / Massachusetts General Brigham Cancer Institute
Search is free. It just needs an account.
We will run “” as soon as you are signed in.
CME Wizard is built for clinicians. A free account lets you search 33,000+ accredited courses, save searches and track credits. Asking for it is also how we keep bots and scrapers out.
Sign Up or Log In to Continue
You need an account to use this feature.
Create your free profile to save courses, track credits, and access your personalized CME hub.
You’re leaving CMEWizard for Medscape, LLC
We did our best with 33,000+ activities. When you’re done, let us know if this one delivered.
“I found better CME, from providers I hadn’t even heard of before.”